Diabetes treatment is constantly evolving, with new therapeutic options emerging to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions of https://sahilqcvd572910.idblogmaker.com/37926974/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment